Issue 40, 2021

Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide

Abstract

A CD9-binding peptide (RSHRLRLH), screened from EWI-2, was characterized, and its effect on cellular migration and invasion was evaluated. As CD9 protein is overexpressed in cancer cells and plays an important role in cellular migration, the CD9-binding peptide preferentially inhibited the migration of cancer cells. Unlike conventional antiproliferative drugs, this CD9-binding peptide is promising as a novel precision antimigratory agent for cancer therapeutics.

Graphical abstract: Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide

Supplementary files

Article information

Article type
Communication
Submitted
10 Mar 2021
Accepted
09 Apr 2021
First published
19 Apr 2021

Chem. Commun., 2021,57, 4906-4909

Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide

T. Suwatthanarak, M. Tanaka, Y. Miyamoto, K. Miyado and M. Okochi, Chem. Commun., 2021, 57, 4906 DOI: 10.1039/D1CC01295A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements